dizziness and semaglutide Is Vertigo a Side Effect of Wegovy? Balance Issues Explained Vertigo from GLP-1 Injections -

Sugar rush or sugar crash

Our Oral GLP-1 Programme Proprietary delivery technology microencapsulates peptides for oral delivery to a specific area of the gut, using pH sensitive release mechanism to deliver the drug to its intended site of action Potential to overcome oral delivery challenges of peptide-based biologicals Effectiveness of the technology has already been validated via the commercialisation of encapsulated oral probiotics and nutraceuticals by AnaBio Technologies, our collaborative partner Proof of Concept Trial Proof of Concept Trial Progressing towards proof of concept trial to determine that a GLP-1R agonist can be successfully delivered orally in humans expected to commence H2 2026, with the potential for partnering on positive data

Schlosburg, J

If you experience unexpected reactions or efficacy loss, your pharmacist can investigate batch-specific issues and coordinate with PlexusDx clinical support